Lumbosacral plexopathy secondary to perirectal abscess in a patient with HIV infection

Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.

The journal of prevention of Alzheimer's disease·2017

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.

Clinical pharmacology and therapeutics·2015

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

Genes, brain, and behavior·2012

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

Neurology·2012

White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics·2011

Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease.

Neurology·2011

Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex.

Neurology·2026

Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest (SUPER-CAT Study).

Neurology·2026

What Is the Role of the Locus Coeruleus in Sleep, Cerebrovascular Control, and Glymphatic Clearance?

Neurology·2026

Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.

Neurology·2026

Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

Neurology·2026

Association of Skin Denervation With Brain Atrophy and Cognitive Impairment in Patients With Parkinson Disease.

Neurology·2026

Related Experiment Videos

Lumbosacral plexopathy secondary to perirectal abscess in a patient with HIV infection

Related Concept Videos

Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer's Disease and Other Tauopathies.

Current thinking on the mechanistic basis of Alzheimer's and implications for drug development.

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS.

CSF VILIP-1 predicts rates of cognitive decline in early Alzheimer disease.

White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism.

Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease.

Quantitative Relationship Between Lumipulse G Measures of pTau217 in Plasma and the Temporal Cortex.

Dual Antiglutamate Therapy in Super-Refractory Status Epilepticus After Cardiac Arrest (SUPER-CAT Study).

What Is the Role of the Locus Coeruleus in Sleep, Cerebrovascular Control, and Glymphatic Clearance?

Ofatumumab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis: A Nationwide Cohort Study.

Medium-Term Cognitive Outcome in Patients With CNS Lymphomas Treated With Chimeric Antigen Receptor T-Cell Therapy.

Association of Skin Denervation With Brain Atrophy and Cognitive Impairment in Patients With Parkinson Disease.

Related Experiment Videos

Lumbosacral plexopathy secondary to perirectal abscess in a patient with HIV infection

Related Concept Videos

Related Articles